A Study To Learn More About the Numbers of Specific Type of Cells (ILC2) Found in the Blood of Men and Women with Asthma
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-006227
Sponsor Protocol Number: 17-006227
About this study
The purpose of this study is to learn about why asthma is different in men and women.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Atopic Asthma
- Physician diagnosed asthma with demonstrated reversibility of bronchoconstriction.
- Patients should also have evidence of allergic sensitization via new or existing skin testing to aeroallergens or IgE serum immunoassay testing to aeroallergens.
Normal Controls:
- Normal controls are healthy individuals with no history of allergy, asthma or sinus disease.
Exclusion Criteria:
- Patients who have received systemic glucocorticoids during the past 4 weeks (topical not excluded)
- Current smokers or within the past year (previous smokers must have < 10 pack/year history)
- Diagnosed with an immunodeficiency or cystic fibrosis
- Immunotherapy for any allergen
- Pregnancy
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Kathleen Bartemes, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available